Pharmacy Report Archives - Page 124 of 150 - Becker's Hospital Review

Price-fixing allegations: Cigna, states sue dozens of drugmakers | Amazon to build diagnostic labs | FEMA plans call for extended PPE reuse | 3 end-stage COVID-19 vaccine trials to start this summer

June 11, 2020 BHR Newsletter Upcoming Webinars • Recent Whitepapers • Podcasts 1. States sue 26 generic drugmakers, accused of fixing prices since 2016 Full story 2. Cigna sues dozens of drugmakers in alleged price-fixing scheme Full story 3. CMS encourages resumption…

50 top OTC health products, rated by pharmacists | OptumRx: 3 drugs to watch | Ariz. physicians sue HHS over hydroxychloroquine access | Fauci warns against pricing limits for COVID-19 drugs

June 10, 2020 BHR Newsletter Upcoming Webinars • Recent Whitepapers • Podcasts 1. Pharmacist recommended: 50 top over-the-counter health products Full story 2. Eligible outpatient sites can use 340B drugs up to 22 months earlier with new HRSA guidance Full story 3.…

340B purchases grew 23% last year | Walgreens underpaid call center staff, suit claims | Houston hospital to close | Number of pharmacists working in hospitals hits new high

June 9, 2020 BHR Newsletter Upcoming Webinars • Recent Whitepapers • Podcasts 1. Number of pharmacists working in hospitals hits new high Full story 2. Purchases through 340B drug pricing program grew 23% in 2019 Full story 3. Florida pharmacy owners charged…

Donated remdesivir supply to run out by July | FDA vaccine head quits Operation Warp Speed | AstraZeneca approaches Gilead about $240B merger | Pharma layoffs slow | 2 more drugmakers recall diabetes med

June 8, 2020 BHR Newsletter Upcoming Webinars • Recent Whitepapers • Podcasts 1. FDA's vaccine head quits Operation Warp Speed days after joining Full story 2. Donated supply of remdesivir in US to run out by month's end Full story 3. Teva, Marksans…

Average pharmacist salary by practice setting | WHO resumes hydroxychloroquine trial | Top 5 COVID-19 vaccine candidates selected | 60 Chicago pharmacies closed amid unrest; patients struggle to get meds

June 4, 2020 BHR Newsletter Upcoming Webinars • Recent Whitepapers • Podcasts 1. White House selects 5 COVID-19 vaccine candidates to prioritize Full story 2. Pharmacist salaries across the most common work settings Full story 3. Chicagoans struggle to get prescriptions amid…

The Lancet questions study that halted COVID-19 drug trial | 100M COVID-19 vaccine doses can be ready by '21 | Watchdog slams FDA oversight of foreign drugmakers | Researchers test anti-platelet, heart drugs for COVID-19

June 3, 2020 BHR Newsletter Upcoming Webinars • Recent Whitepapers • Podcasts 1. Merck CEO urges business leaders to help bridge racial opportunity gap Full story 2. Top medical journal raises doubts about study that led WHO to pause COVID-19 drug…

Shortage of antidepressant emerges | FDA asks 5 drugmakers to recall diabetes med | Gilead: Remdesivir helps moderate COVID-19 cases | 5 CMS pharmacy policy changes to know

June 2, 2020 BHR Newsletter Upcoming Webinars • Recent Whitepapers • Podcasts 1. Zoloft antidepressant in shortage due to increased demand during pandemic Full story 2. Some pandemic-inspired FDA changes will stick, commissioner says Full story 3. Remdesivir benefits moderate COVID-19 patients,…

EHRs detect harmful med errors 66% of the time: Study | 1st shipments of remdesivir botched | CVS to deliver prescriptions in self-driving cars | Eli Lilly tests COVID-19 antibody drug | Top 5 pharma stories in May

June 1, 2020 BHR Newsletter Upcoming Webinars • Recent Whitepapers • Podcasts 1. EHRs have slightly increased medication safety performance over the last decade: Study Full story 2. Eli Lilly testing COVID-19 drug derived from survivor blood Full story 3. Immunomedics CEO…

6 BCBS plans sue CVS, alleging fraud | FDA finds carcinogen in diabetes med | Thyroid drug recalled for super potency | Pharmacists argue drugs should get quality scores

May 28, 2020 BHR Newsletter Upcoming Webinars • Recent Whitepapers • Podcasts 1. FDA finds 'unacceptable' levels of carcinogen in popular diabetes drug Full story 2. 6 BCBS companies sue CVS, claiming decadelong insurance fraud scheme Full story 3. Pharmacists, researchers argue…

How states are distributing remdesivir | Pharmacy chains gave bonuses to pharmacists dispensing high opioid volumes, suit alleges | CMS: 1,750 Part D drug plans to cap insulin costs | NY pharmacist charged in mask profiteering scheme

May 27, 2020 BHR Newsletter Upcoming Webinars • Recent Whitepapers • Podcasts 1. Pharmacy chains helped fuel opioid crisis, paid bonuses to high-volume pharmacists, complaint alleges Full story 2. Drugmakers worried about Washington's push to bring drug manufacturing back to US Full…